- Home
- IMCR vs SFL Comparison
IMCR vs SFL Comparison
Compare IMCR & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- SFL
- Stock Information
- Founded
- IMCR 2008
- SFL 2003
- Country
- IMCR United Kingdom
- SFL Bermuda
- Employees
- IMCR N/A
- SFL N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- SFL Marine Transportation
- Sector
- IMCR Health Care
- SFL Consumer Discretionary
- Exchange
- IMCR Nasdaq
- SFL Nasdaq
- Market Cap
- IMCR 1.8B
- SFL 1.1B
- IPO Year
- IMCR 2021
- SFL N/A
- Fundamental
- Price
- IMCR $33.42
- SFL $8.06
- Analyst Decision
- IMCR Buy
- SFL Strong Buy
- Analyst Count
- IMCR 9
- SFL 1
- Target Price
- IMCR $57.00
- SFL $13.00
- AVG Volume (30 Days)
- IMCR 280.0K
- SFL 1.2M
- Earning Date
- IMCR 11-05-2025
- SFL 11-05-2025
- Dividend Yield
- IMCR N/A
- SFL 13.38%
- EPS Growth
- IMCR N/A
- SFL N/A
- EPS
- IMCR N/A
- SFL 0.26
- Revenue
- IMCR $356,145,000.00
- SFL $852,528,000.00
- Revenue This Year
- IMCR $29.67
- SFL N/A
- Revenue Next Year
- IMCR $11.12
- SFL $2.63
- P/E Ratio
- IMCR N/A
- SFL $31.40
- Revenue Growth
- IMCR 26.78
- SFL 3.21
- 52 Week Low
- IMCR $23.15
- SFL $6.78
- 52 Week High
- IMCR $39.33
- SFL $11.85
- Technical
- Relative Strength Index (RSI)
- IMCR 44.21
- SFL 41.34
- Support Level
- IMCR $35.33
- SFL $7.93
- Resistance Level
- IMCR $36.76
- SFL $8.18
- Average True Range (ATR)
- IMCR 1.57
- SFL 0.16
- MACD
- IMCR -0.20
- SFL 0.02
- Stochastic Oscillator
- IMCR 24.65
- SFL 28.89
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About SFL SFL Corporation Ltd
SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities.